The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
The neurobiology of antiepileptic drugs
Abstract
Antiepileptic drugs (AEDs) provide satisfactory control of seizures for most patients with epilepsy. The drugs have the remarkable ability to protect against seizures while permitting normal functioning of the nervous system. AEDs act on diverse molecular targets to selectively modify the excitability of neurons so that seizure-related firing is blocked without disturbing non-epileptic activity. This occurs largely through effects on voltage-gated sodium and calcium channels, or by promoting inhibition mediated by GABAA (γ-aminobutyric acid, type A) receptors. The subtle biophysical modifications in channel behaviour that are induced by AEDs are often functionally opposite to defects in channel properties that are caused by mutations associated with epilepsy in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glutamate receptor ion channels
Mayer, M. L. (2005) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2005.05.004 · Cited by 3,640
Structure and Regulation of Voltage-Gated Ca 2+ Channels
Catterall, W. A. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.521 · Cited by 2,344
Macdonald, R. L., & Olsen, R. W. (1994) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.17.030194.003033 · Cited by 1,975
Molecular Physiology of Low-Voltage-Activated T-type Calcium Channels
Perez-Reyes, E. (2003) · Physiological Reviews · doi:10.1152/physrev.00018.2002 · Cited by 1,652
The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam
Lynch, B. A., Lambeng, N., Nocka, K., Kensel-Hammes, P., Bajjalieh, S. M., Matagne, A., & Fuks, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308208101 · Cited by 1,610
The Novel Anticonvulsant Drug, Gabapentin (Neurontin), Binds to the α2δ Subunit of a Calcium Channel
Gee, N. S., Brown, J. P., Dissanayake, V. U. K., Offord, J., Thurlow, R., & Woodruff, G. N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5768 · Cited by 1,181
Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes
Rudolph, U., Crestani, F., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Martin, J. R., Bluethmann, H., & Möhler, H. (1999) · Nature · doi:10.1038/44579 · Cited by 1,172
Bormann, J., Hamill, O. P., & Sakmann, B. (1987) · The Journal of Physiology · doi:10.1113/jphysiol.1987.sp016493 · Cited by 1,157
Talley, E. M., Cribbs, L. L., Lee, J.-H., Daud, A., Perez-Reyes, E., & Bayliss, D. A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-06-01895.1999 · Cited by 790
Mutant GABAA receptor γ2-subunit in childhood absence epilepsy and febrile seizures
Wallace, R. H., Marini, C., Petrou, S., Harkin, L. A., Bowser, D. N., Panchal, R. G., Williams, D. A., Sutherland, G. R., Mulley, J. C., Scheffer, I. E., et al. (2001) · Nature Genetics · doi:10.1038/ng0501-49 · Cited by 781
First genetic evidence of GABAA receptor dysfunction in epilepsy: a mutation in the γ2-subunit gene
Baulac, S., Huberfeld, G., Gourfinkel-An, I., Mitropoulou, G., Beranger, A., Prud'homme, J.-F., Baulac, M., Brice, A., Bruzzone, R., & LeGuern, E. (2001) · Nature Genetics · doi:10.1038/ng0501-46 · Cited by 766
Low-Threshold Calcium Currents in Central Nervous System Neurons
Huguenard, J. R. (1996) · Annual Review of Physiology · doi:10.1146/annurev.ph.58.030196.001553 · Cited by 763
Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy
Cossette, P., Liu, L., Brisebois, K., Dong, H., Lortie, A., Vanasse, M., Saint-Hilaire, J.-M., Carmant, L., Verner, A., Lu, W.-Y., et al. (2002) · Nature Genetics · doi:10.1038/ng885 · Cited by 655
Leach, M. J., Marden, C. M., & Miller, A. A. (1986) · Epilepsia · doi:10.1111/j.1528-1157.1986.tb03573.x · Cited by 549
Schuler, V., Lüscher, C., Blanchet, C., Klix, N., Sansig, G., Klebs, K., Schmutz, M., Heid, J., Gentry, C., Urban, L., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00345-2 · Cited by 538
Kim, D., Song, I., Keum, S., Lee, T., Jeong, M.-J., Kim, S.-S., McEnery, M. W., & Shin, H.-S. (2001) · Neuron · doi:10.1016/s0896-6273(01)00343-9 · Cited by 522
Löscher, W. (2002) · Epilepsy Research · doi:10.1016/s0920-1211(02)00073-6 · Cited by 509
Self-citationAuxiliary subunits: essential components of the voltage-gated calcium channel complex
Arikkath, J., & Campbell, K. P. (2003) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(03)00066-7 · Cited by 505
Characterization of ethosuximide reduction of low‐threshold calcium current in thalamic neurons
Coulter, D. A., Huguenard, J. R., & Prince, D. A. (1989) · Annals of Neurology · doi:10.1002/ana.410250610 · Cited by 504
Ragsdale, D. S., McPhee, J. C., Scheuer, T., & Catterall, W. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9270 · Cited by 498
The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions
Rogawski, M. A., & Löscher, W. (2004) · Nature Medicine · doi:10.1038/nm1074 · Cited by 456
Self-citationHarkin, L. A., Bowser, D. N., Dibbens, L. M., Singh, R., Phillips, F., Wallace, R. H., Richards, M. C., Williams, D. A., Mulley, J. C., Berkovic, S. F., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/338710 · Cited by 441
Galarreta, M., & Hestrin, S. (1998) · Nature Neuroscience · doi:10.1038/2822 · Cited by 431
Tsakiridou, E., Bertollini, L., de Curtis, M., Avanzini, G., & Pape, H. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-04-03110.1995 · Cited by 423
Escayg, A., De Waard, M., Lee, D. D., Bichet, D., Wolf, P., Mayer, T., Johnston, J., Baloh, R., Sander, T., & Meisler, M. H. (2000) · The American Journal of Human Genetics · doi:10.1086/302909 · Cited by 423
Tatulian, L., Delmas, P., Abogadie, F. C., & Brown, D. A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05535.2001 · Cited by 406
Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel
Jouvenceau, A., Eunson, L. H., Spauschus, A., Ramesh, V., Zuberi, S. M., Kullmann, D. M., & Hanna, M. G. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05971-2 · Cited by 387
Association between genetic variation of CACNA1H and childhood absence epilepsy
Chen, Y., Lu, J., Pan, H., Zhang, Y., Wu, H., Xu, K., Liu, X., Jiang, Y., Bao, X., Yao, Z., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10607 · Cited by 380
Inhibitory control of local excitatory circuits in the guinea‐pig hippocampus.
Miles, R., & Wong, R. K. (1987) · The Journal of Physiology · doi:10.1113/jphysiol.1987.sp016634 · Cited by 375
Molecular Basis of an Inherited Epilepsy
Lossin, C., Wang, D. W., Rhodes, T. H., Vanoye, C. G., & George, A. L. (2002) · Neuron · doi:10.1016/s0896-6273(02)00714-6 · Cited by 361
Bai, D., Zhu, G., Pennefather, P., Jackson, M. F., MacDonald, J. F., & Orser, B. A. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.4.814 · Cited by 358
White, H. S., Brown, S. D., Woodhead, J. H., Skeen, G. A., & Wolf, H. H. (1997) · Epilepsy Research · doi:10.1016/s0920-1211(97)00045-4 · Cited by 356
Selective Blockade of N‐Type Calcium Channels by Levetiracetam
Lukyanetz, E. A., Shkryl, V. M., & Kostyuk, P. G. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.24501.x · Cited by 338
Gallagher, J. P., Higashi, H., & Nishi, S. (1978) · The Journal of Physiology · doi:10.1113/jphysiol.1978.sp012189 · Cited by 318
Molecular Physiology of Kainate Receptors
Lerma, J., Paternain, A. V., Rodríguez-Moreno, A., & López-García, J. C. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.3.971 · Cited by 307
Mechanism of action of the hypnotic zolpidem in vivo
Crestani, F., Martin, J. R., Möhler, H., & Rudolph, U. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703717 · Cited by 307
Fleidervish, I. A., Friedman, A., & Gutnick, M. J. (1996) · The Journal of Physiology · doi:10.1113/jphysiol.1996.sp021366 · Cited by 303
Taddese, A., & Bean, B. P. (2002) · Neuron · doi:10.1016/s0896-6273(02)00574-3 · Cited by 302
Na+ channels must deactivate to recover from inactivation
Kuo, C.-C., & Bean, B. P. (1994) · Neuron · doi:10.1016/0896-6273(94)90335-2 · Cited by 293
Dynamic Equilibrium of Neurotransmitter Transporters: Not Just for Reuptake Anymore
Richerson, G. B., & Wu, Y. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00317.2003 · Cited by 291
A Splice-Site Mutation in GABRG2 Associated With Childhood Absence Epilepsy and Febrile Convulsions
Kananura, C., Haug, K., Sander, T., Runge, U., Gu, W., Hallmann, K., Rebstock, J., Heils, A., & Steinlein, O. K. (2002) · Archives of Neurology · doi:10.1001/archneur.59.7.1137 · Cited by 280
Suzdak, P. D., & Jansen, J. A. (1995) · Epilepsia · doi:10.1111/j.1528-1157.1995.tb02576.x · Cited by 278
McLean, M. J., & Macdonald, R. L. (1986) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24966-7 · Cited by 273
Thompson, S. M., & Gahwiler, B. H. (1992) · Journal of Neurophysiology · doi:10.1152/jn.1992.67.6.1698 · Cited by 263
Calcium Channel α2δ Subunits—Structure and Gabapentin Binding
Marais, E., Klugbauer, N., & Hofmann, F. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.5.1243 · Cited by 262
Xie, X., Lancaster, B., Peakman, T., & Garthwaite, J. (1995) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/bf00373920 · Cited by 249
Functional Analysis of the Mouse Scn8a Sodium Channel
Smith, M. R., Smith, R. D., Plummer, N. W., Meisler, M. H., & Goldin, A. L. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-16-06093.1998 · Cited by 248
Mechanisms of sodium channel inactivation
Goldin, A. L. (2003) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(03)00065-5 · Cited by 247
Sutton, K. G., Martin, D. J., Pinnock, R. D., Lee, K., & Scott, R. H. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704439 · Cited by 240
Willow, M., Gonoi, T., & Catterall, W. A. (1985) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)12546-7 · Cited by 229
Inhibition of K+-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin
Dooley, D. J., Mieske, C. A., & Borosky, S. A. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)00769-2 · Cited by 226
Ragsdale, D. S., Scheuer, T., & Catterall, W. A. (1991) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)15395-9 · Cited by 226
Niespodziany, I., Klitgaard, H., & Margineanu, D. G. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01884-5 · Cited by 220
T-type calcium channels mediate the transition between tonic and phasic firing in thalamic neurons.
Suzuki, S., & Rogawski, M. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.18.7228 · Cited by 217
Self-citationGryder, D. S., & Rogawski, M. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-18-07069.2003 · Cited by 216
Self-citationBlock of Cloned Human T-Type Calcium Channels by Succinimide Antiepileptic Drugs
Gomora, J. C., Daud, A. N., Weiergräber, M., & Perez-Reyes, E. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12522-9 · Cited by 216
Maurice, N., Tkatch, T., Meisler, M., Sprunger, L. K., & Surmeier, D. J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-07-02268.2001 · Cited by 214
Kuo, C.-C. (1998) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)13073-8 · Cited by 212
Slow binding of phenytoin to inactivated sodium channels in rat hippocampal neurons.
Kuo, C. C., & Bean, B. P. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09804-9 · Cited by 205
Lamotrigine inhibits Ca2+ currents in cortical neurons: functional implications
Stefani, A., Spadoni, F., Siniscalchi, A., & Bernardi, G. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00265-8 · Cited by 200
Gabapentin increases aminooxyacetic acid-induced GABA accumulation in several regions of rat brain
Löscher, W., Hönack, D., & Taylor, C. P. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90249-s · Cited by 193
Self-citationSpampanato, J., Escayg, A., Meisler, M. H., & Goldin, A. L. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07481.2001 · Cited by 191
Gabapentin affects glutamatergic excitatory neurotransmission in the rat dorsal horn
Shimoyama, M., Shimoyama, N., & Hori, Y. (2000) · Pain · doi:10.1016/s0304-3959(99)00283-3 · Cited by 189
On the Action of the Anti-Absence Drug Ethosuximide in the Rat and Cat Thalamus
Leresche, N., Parri, H. R., Erdemli, G., Guyon, A., Turner, J. P., Williams, S. R., Asprodini, E., & Crunelli, V. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-13-04842.1998 · Cited by 187
Khosravani, H., Altier, C., Simms, B., Hamming, K. S., Snutch, T. P., Mezeyova, J., McRory, J. E., & Zamponi, G. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400006200 · Cited by 186
Inhibition of Transient and Persistent Na+ Current Fractions by the New Anticonvulsant Topiramate
Taverna, S., Sancini, G., Mantegazza, M., Franceschetti, S., & Avanzini, G. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38047-4 · Cited by 184
Dooley, D. J., Donovan, C. M., Meder, W. P., & Whetzel, S. Z. (2002) · Synapse · doi:10.1002/syn.10094 · Cited by 180
A Critical Role for Transmembrane Segment IVS6 of the Sodium Channel α Subunit in Fast Inactivation
McPhee, J. C., Ragsdale, D. S., Scheuer, T., & Catterall, W. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.20.12025 · Cited by 174
Cortical-area specific block of genetically determined absence seizures by ethosuximide
Manning, J.-P. A., Richards, D. A., Leresche, N., Crunelli, V, & Bowery, N. G. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.09.026 · Cited by 171
Effect of Inhibitors of GABA Transaminase on the Synthesis, Binding, Uptake and Metabolism of GABA
Löscher, W. (1980) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1980.tb11250.x · Cited by 166
Self-citationWu, Y., Wang, W., & Richerson, G. B. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00856.2002 · Cited by 155
Talley, E. M., Solórzano, G., Depaulis, A., Perez‐Reyes, E., & Bayliss, D. A. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00307-1 · Cited by 152
Levetiracetam does not modulate neuronal voltage-gated Na and T-type Ca currents
Zona, C., Niespodziany, I., Marchetti, C., Klitgaard, H., Bernardi, G., & Margineanu, D. G. (2001) · Seizure · doi:10.1053/seiz.2000.0504 · Cited by 149
Mechanisms of T-type calcium channel blockade by zonisamide
Kito, M., Maehara, M., & Watanabe, K. (1996) · Seizure · doi:10.1016/s1059-1311(96)80104-x · Cited by 149
Characterization of lamotrigine inhibition of Na+ channels in rat hippocampal neurones
Kuo, C., & Lu, L. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701221 · Cited by 148
Martin, D. J., McClelland, D. E., Herd, M. B., Sutton, K. G., Hall, M. D., Lee, K., Pinnock, R. D., & Scott, R. H. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(01)00181-2 · Cited by 148
Antagonists of GLUK5-containing kainate receptors prevent pilocarpine-induced limbic seizures
Smolders, I. J., Bortolotto, Z. A., Clarke, V. R. J., Warre, R., Khan, G. M., O’Neill, M. J., Ornstein, P. L., Bleakman, D., Ogden, A.-M., Weiss, B., et al. (2002) · Nature Neuroscience · doi:10.1038/nn880 · Cited by 147
Bianchi, M. T., Song, L., Zhang, H., & Macdonald, R. L. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-13-05321.2002 · Cited by 143
The genetics of human epilepsy
Scheffer, I. E., & Berkovic, S. F. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00194-9 · Cited by 143
Animal models of epileptogenesis
White, H. S. (2002) · Neurology · doi:10.1212/wnl.59.9_suppl_5.s7 · Cited by 138
Ellerkmann, R. K., Remy, S., Chen, J., Гарриевич, С. Д., Elger, C. E., Urban, B. W., Becker, A. J., & Beck, H. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00168-4 · Cited by 132
Structural requirement of the calcium-channel subunit α2δ for gabapentin binding
Wang, M., Offord, J., Oxender, D. L., & Su, T. (1999) · Biochemical Journal · doi:10.1042/bj3420313 · Cited by 129
Topiramate selectively protects against seizures induced by ATPA, a GluR5 kainate receptor agonist
Kaminski, R. M., Banerjee, M., & Rogawski, M. A. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.02.010 · Cited by 129
Self-citationDOLPHIN, A. C., Wyatt, C. N., Richards, J., Beattie, R., Craig, P. J., Lee, J. ‐., Cribbs, L. L., Volsen, S. G., & Perez‐Reyes, E. (1999) · The Journal of Physiology · doi:10.1111/j.1469-7793.1999.0035o.x · Cited by 129
Segal, M. M., & Douglas, A. F. (1997) · Journal of Neurophysiology · doi:10.1152/jn.1997.77.6.3021 · Cited by 128
Genetic variation of CACNA1H in idiopathic generalized epilepsy
Heron, S. E., Phillips, H. A., Mulley, J. C., Mazarib, A., Neufeld, M. Y., Berkovic, S. F., & Scheffer, I. E. (2004) · Annals of Neurology · doi:10.1002/ana.20028 · Cited by 127
GABA Transporters and GABA-Transaminase as Drug Targets
Sarup, A., Larsson, O. M., & Schousboe, A. (2003) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007033482788 · Cited by 122
Inhibition of N-type calcium currents by lamotrigine in rat amygdalar neurones
Wang, S., Huang, C., Hsu, K., Tsai, J.-J., & Gean, P. (1996) · Neuroreport · doi:10.1097/00001756-199611250-00048 · Cited by 121
Paradoxical Reduction of Synaptic Inhibition by Vigabatrin
Overstreet, L. S., & Westbrook, G. L. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.86.2.596 · Cited by 115
Selective Depression of Low–Release Probability Excitatory Synapses by Sodium Channel Blockers
Prakriya, M., & Mennerick, S. J. (2000) · Neuron · doi:10.1016/s0896-6273(00)81203-9 · Cited by 113
ffrench-Mullen, J. M. H., Barker, J. L., & Rogawski, M. A. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-08-03211.1993 · Cited by 110
Self-citationEffects of Gabapentin on Brain GABA, Homocarnosine, and Pyrrolidinone in Epilepsy Patients
Petroff, O. A. C., Hyder, F., Rothman, D. L., & Mattson, R. H. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb00227.x · Cited by 108
Association between the α 1a calcium channel gene CACNA1A and idiopathic generalized epilepsy
Chioza, B. A., Wilkie, H., Nashef, L. A. M., Blower, J., McCormick, D., Sham, P. C., Asherson, P. J., & MAKOFF, A. J. (2001) · Neurology · doi:10.1212/wnl.56.9.1245 · Cited by 107
Sarantopoulos, C. D., McCallum, B., Kwok, W. W., & Hogan, Q. H. (2002) · Regional Anesthesia & Pain Medicine · doi:10.1053/rapm.2002.29124 · Cited by 103
Liu, G., Yarov-Yarovoy, V. M., Nobbs, M. S., Clare, J. J., Scheuer, T., & Catterall, W. A. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(02)00400-8 · Cited by 99
Sohal, V. S., Keist, R., Rudolph, U., & Huguenard, J. R. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-09-03649.2003 · Cited by 94
Valproate and sodium currents in cultured hippocampal neurons
van den Berg, R. J., Kok, P., & Voskuyl, R. A. (1993) · Experimental Brain Research · doi:10.1007/bf00228395 · Cited by 92
Valproate selectively reduces the persistent fraction of Na+ current in neocortical neurons
Taverna, S., Mantegazza, M., Franceschetti, S., & AVANZINI, G. (1998) · Epilepsy Research · doi:10.1016/s0920-1211(98)00060-6 · Cited by 90
Felbamate block of recombinant N-methyl-d-aspartate receptors: selectivity for the NR2B subunit
Harty, T. P., & Rogawski, M. A. (2000) · Epilepsy Research · doi:10.1016/s0920-1211(99)00108-4 · Cited by 90
Self-citationBryans, J. S., Davies, N., GEE, N. S., Dissanayake, V. U. K., Ratcliffe, G. S., Horwell, D. C., Kneen, C. O., Morrell, A. I., Oles, R. J., O'Toole, J. C., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970649n · Cited by 90
Effects of phenytoin on the persistent Na+ current of mammalian CNS neurones
Chao, T. I., & Alzheimer, C. (1995) · Neuroreport · doi:10.1097/00001756-199509000-00017 · Cited by 87
Felbamate block of the N-methyl-D-aspartate receptor.
Subramaniam, S., Rho, J. M., Penix, L. P., Donevan, S. D., Fielding, R. P., & Rogawski, M. A. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)09605-3 · Cited by 85
Self-citationBarbiturate-Like Actions of the Propanediol Dicarbamates Felbamate and Meprobamate
Rho, J. M., Donevan, S. D., & Rogawski, M. A. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36535-8 · Cited by 82
Self-citationKleckner, N. W., Glazewski, J. C., Chen, C. C., & Moscrip, T. D. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38215-1 · Cited by 81
Gabapentin and vigabatrin increase GABA in the human neocortical slice
Errante, L. D., Williamson, A., Spencer, D. D., & Petroff, O. A. C. (2002) · Epilepsy Research · doi:10.1016/s0920-1211(02)00034-7 · Cited by 78
Cloning and Deletion Mutagenesis of the α2δ Calcium Channel Subunit from Porcine Cerebral Cortex
Brown, J. P., & GEE, N. S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.39.25458 · Cited by 75
L�scher, W., & H�rstermann, D. (1994) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00169293 · Cited by 74
Self-citationKetelaars, S. O. M., Gorter, J. A., van Vliet, E. A., et al. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00176-2 · Cited by 72
Laminar difference in GABA uptake and GAT‐1 expression in rat CA1
Engel, D., Schmitz, D., Gloveli, T., Frahm, C., Heinemann, U., & Draguhn, A. (1998) · The Journal of Physiology · doi:10.1111/j.1469-7793.1998.643bd.x · Cited by 72
Xie, X., Dale, T. J., John, V. H., Cater, H. L., Peakman, T. C., & Clare, J. J. (2001) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240000448 · Cited by 71
Alekov, A. K., Rahman, M. M., Mitrović, N., Lehmann‐Horn, F., & Lerche, H. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01590.x · Cited by 68
Agrawal, N., Alonso, Á., & Ragsdale, D. S. (2003) · Epilepsia · doi:10.1111/j.0013-9580.2003.23103.x · Cited by 68
Spampanato, J. G., Aradi, I., Soltész, I., & Goldin, A. L. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00982.2003 · Cited by 68
Ionotropic Glutamate Receptors as Therapeutic Targets
Jellinger, K. A. (2004) · European Journal of Neurology · doi:10.1111/j.1468-1331.2004.00786.x · Cited by 67
GluR5 Kainate Receptors, Seizures, and the Amygdala
Rogawski, M. A., Gryder, D. S., Castaneda, D. C., Yonekawa, W. D., BANKS, M. K., & LI, H. E. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07079.x · Cited by 66
Self-citationLampl, I., Schwindt, P. C., & Crill, W. E. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37226-x · Cited by 64
Gordey, M., DeLorey, T. M., & Olsen, R. W. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb02167.x · Cited by 58
Progressive Encephalopathy Due to Chronic Hydantoin Intoxication
Vallarta, J. M. (1974) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1974.02110260029006 · Cited by 58
Modification of slow inactivation of single sodium channels by phenytoin in neuroblastoma cells.
Quandt, F. N. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09773-1 · Cited by 57
Biase, D. D., Barra, D., Bossa, F., Pucci, P., & John, R. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54890-0 · Cited by 56
Felbamate inhibits cloned voltage-dependent Na+ channels from human and rat brain
Taglialatela, M., Ongini, E., Brown, A. M., Renzo, G. D., & Annunziato, L. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00802-3 · Cited by 43
Kuo, C., Lin, B., Chang, H.-R., & Hsieh, C.-P. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.2.370 · Cited by 40
Is the persistent sodium current a specific target of anti-absence drugs?
Niespodziany, I., Klitgaard, H., & Margineanu, D. G. (2004) · Neuroreport · doi:10.1097/00001756-200404290-00023 · Cited by 39
Kainate receptor pharmacology and physiology
Bleakman, D. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050453 · Cited by 35
Jackson, M. F., Esplin, B. A., & Čapek, R. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00075-1 · Cited by 35
Chioza, B. A., Osei‐Lah, A. D., Nashef, L. A. M., Suárez-Merino, B., Wilkie, H., Sham, P. C., Knight, J., Asherson, P. J., & MAKOFF, A. J. (2002) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200896 · Cited by 32
Jackson, M. F., Esplin, B. A., & Čapek, R. (1999) · Epilepsy Research · doi:10.1016/s0920-1211(99)00029-7 · Cited by 27
Neurotherapeutics: Emerging strategies
(1996) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(96)90025-7 · Cited by 24
Human epilepsy, episodic ataxia type 2, and migraine
Holtmann, M. H., Opp, J., Tokarzewski, M., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07355-5 · Cited by 16
Limbic epileptogenesis alters the anticonvulsant efficacy of phenytoin in Sprague–Dawley rats
Löscher, W., Cramer, S., & Ebert, U. (1998) · Epilepsy Research · doi:10.1016/s0920-1211(98)00029-1 · Cited by 15
Self-citationAkaike, N., Inomata, N., & Yakushiji, T. (1989) · Journal of Neurophysiology · doi:10.1152/jn.1989.62.6.1388 · Cited by 14
Rogawski, M. A. (1996) · Humana Press eBooks · doi:10.1007/978-1-59259-466-5_6 · Cited by 7
Self-citation
Cited by
The role of inflammation in epilepsy
Vezzani, A., French, J., Bartfai, T., & Baram, T. Z. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.178 · Cited by 1,876
Devinsky, O., Vezzani, A., O'Brien, T. J., Jette, N., Scheffer, I. E., de Curtis, M., & Perucca, P. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.24 · Cited by 959
Löscher, W. (2011) · Seizure · doi:10.1016/j.seizure.2011.01.003 · Cited by 932
Self-citationLöscher, W., Potschka, H., Sisodiya, S. M., & Vezzani, A. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019539 · Cited by 903
Self-citationDrug resistance in brain diseases and the role of drug efflux transporters
Löscher, W., & Potschka, H. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1728 · Cited by 900
Self-citation
Metadata
- Authors
- Rogawski, M. A., & Löscher, W.
- Venue
- Nature Reviews Neuroscience
- Published
- 2004-07
- Volume
- 5
- Issue
- 7
- Pages
- 553-564
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W1987398739
- Cited by
- 1,239
- References
- 132
- FWCI
- 5.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.